DongBang Medical KRX:240550KOSDAQ
동방메디컬 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days2
DART filings, 7 days0
Articles tracked2since Sep 11
In Q2 2026, DongBang Medical reported revenue of ₩33.9bn, up 29.6% year on year, and operating profit of ₩6.4bn. DongBang Medical (동방메디컬) appeared in 2 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 2 articles.
DongBang Medical quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩33.9bn | +29.6% | ₩6.4bn | ₩4.0bn |
| Q1 2026 | ₩31.4bn | +13.9% | ₩6.1bn | ₩5.3bn |
| Q4 2025 derived | ₩29.8bn | +6.0% | ₩5.5bn | ₩3.5bn |
| Q3 2025 | ₩30.0bn | +13.4% | ₩4.1bn | ₩2.8bn |
| Q2 2025 | ₩26.2bn | -0.7% | ₩3.1bn | ₩1.9bn |
| Q1 2025 | ₩27.6bn | +13.9% | ₩4.3bn | ₩3.2bn |
| Q4 2024 derived | ₩28.1bn | – | ₩2.9bn | ₩1.5bn |
| Q3 2024 | ₩26.4bn | – | ₩4.7bn | ₩2.8bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
DongBang Medical top stories 2 weeks, by number of outlets
- 1
Latest DongBang Medical news Korean headlines
-
동방메디컬, 톡신 사업 진출...균주 기업 지분투자 저울질
1 more on this story · 1 outlets
- 동방메디컬, 톡신 사업 진출...균주 기업 지분투자 저울질이데일리 · Sep 14 08:21